BBOT
Price
$11.98
Change
-$0.23 (-1.88%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
966.99M
56 days until earnings call
VKTX
Price
$32.36
Change
+$0.83 (+2.63%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
3.64B
14 days until earnings call
Interact to see
Advertisement

BBOT vs VKTX

Header iconBBOT vs VKTX Comparison
Open Charts BBOT vs VKTXBanner chart's image
BridgeBio Oncology Therapeutics
Price$11.98
Change-$0.23 (-1.88%)
Volume$5.02K
Capitalization966.99M
Viking Therapeutics
Price$32.36
Change+$0.83 (+2.63%)
Volume$91.76K
Capitalization3.64B
BBOT vs VKTX Comparison Chart in %
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. VKTX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a StrongBuy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (BBOT: $12.21 vs. VKTX: $31.53)
Brand notoriety: BBOT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 56% vs. VKTX: 71%
Market capitalization -- BBOT: $966.99M vs. VKTX: $3.64B
BBOT [@Biotechnology] is valued at $966.99M. VKTX’s [@Biotechnology] market capitalization is $3.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BBOT and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 6 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • BBOT’s TA Score: 6 bullish, 3 bearish.
  • VKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BBOT is a better buy in the short-term than VKTX.

Price Growth

BBOT (@Biotechnology) experienced а +5.44% price change this week, while VKTX (@Biotechnology) price change was +20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

BBOT is expected to report earnings on Dec 03, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.64B) has a higher market cap than BBOT($967M). BBOT YTD gains are higher at: 16.286 vs. VKTX (-21.633). BBOT has higher annual earnings (EBITDA): -94.43M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. BBOT (131M). VKTX has less debt than BBOT: VKTX (878K) vs BBOT (2.83M). BBOT (0) and VKTX (0) have equivalent revenues.
BBOTVKTXBBOT / VKTX
Capitalization967M3.64B27%
EBITDA-94.43M-212.42M44%
Gain YTD16.286-21.633-75%
P/E RatioN/AN/A-
Revenue00-
Total Cash131M808M16%
Total Debt2.83M878K323%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTVKTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
7%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
27%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
35%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
26%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
14%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
14%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIVLX13.77N/A
N/A
Fidelity International Value
IRSYX15.68N/A
N/A
Macquarie Real Estate Securities Y
BRSVX38.64N/A
N/A
Bridgeway Small-Cap Value
WBSIX35.68N/A
N/A
William Blair Small Cap Growth I
PRILX66.09-0.31
-0.47%
Parnassus Core Equity Institutional

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and COCP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and COCP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-2.55%
COCP - BBOT
25%
Poorly correlated
-0.82%
VKTX - BBOT
23%
Poorly correlated
-2.31%
PRTC - BBOT
22%
Poorly correlated
-3.29%
RAPP - BBOT
22%
Poorly correlated
-4.69%
VTGN - BBOT
21%
Poorly correlated
+1.80%
More